指南与共识头痛与眩晕

偏头痛fMRI报告标准共识:Delphi研究

Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi Study.
指南 / 共识 · Neurology · 2025-02-10

本研究采用Delphi法,经两轮各三轮问卷,由29名和26名专家对17个报告领域的157条陈述进行评分,达成强共识和共识的条目分别为34条和33条,最终形成涵盖14个领域63个条目的报告清单,用于统一偏头痛fMRI研究的队列特征、采集与分析方案报告。

要点

  • Delphi法两轮问卷共形成63条目、14领域的偏头痛fMRI报告清单。
  • 强共识条目34条,共识条目33条,覆盖人口学、偏头痛特异性因素、扫描参数等。
  • 该框架旨在统一队列特征、fMRI采集与分析方案的报告。

核心结论

  • 研究提出基于专家的偏头痛fMRI研究报告标准框架,可用于未来研究统一队列特征、fMRI采集和分析方案。

研究设计与样本

  • 采用Delphi法,从文献中识别偏头痛fMRI专家,进行两轮各三轮结构化问卷。
  • 第一轮覆盖人口学数据、偏头痛特异性因素、药物、扫描时机、健康对照、采样/招募、标准化表格、研究预注册、感兴趣区分析、验证数据集、数据共享、预处理文档和分析软件。
  • 第二轮覆盖扫描仪相关因素、序列相关因素、生理监测和刺激相关因素。
  • 共157条陈述、17个报告领域,采用5点Likert量表评分(强支持至强反对)。
  • 强共识/共识定义为≥90%/≥75%的参与者评分4或5分。

主要发现

  • 第一轮和第二轮所有三轮分别由来自23家和21家机构的29名和26名研究者完成(年龄46±11岁,38%女性/年龄46±12岁,44%女性)。
  • 两轮合计,强共识条目34条(扫描仪相关因素3条、序列相关因素9条、刺激相关因素1条、人口学因素2条、偏头痛特异性因素7条、药物因素2条、扫描时机因素2条、健康对照因素4条、预注册因素1条、分析软件因素1条、感兴趣区分析因素2条)。
  • 共识条目33条(扫描仪相关因素1条、序列相关因素4条、生理监测相关因素1条、刺激相关因素1条、人口学因素3条、偏头痛特异性因素6条、药物因素4条、健康对照因素3条、采样因素2条、标准化表格1条、预注册因素1条、数据共享因素1条、分析软件因素2条、感兴趣区分析因素3条)。
  • 由强共识和共识条目形成涵盖14个报告领域、63个条目的清单。

关键数值与推荐

  • 强共识定义为≥90%的参与者评分4或5分。
  • 共识定义为≥75%的参与者评分4或5分。
  • 最终清单涵盖14个报告领域、63个条目。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Migraine is a multifaceted primary headache disorder. In neuroimaging of migraine, fMRI has been used to elucidate pathophysiology or monitor treatment effects. The current literature, however, is highly heterogeneous regarding reported variables and methodologies. This begets a lack of comparability and complicates synthesis of results across studies. We developed a framework for standardized reporting of fMRI studies in migraine. METHODS: Experts on fMRI in migraine were identified from the literature and subjected to structured questionnaires in 2 iterations of 3 rounds according to the DELPHI method. A total of 157 statements across 17 reporting domains were rated on 5-point Likert scales (strong support to strong opposition). The first iteration covered demographic data, migraine-specific factors, medication, scan timing, healthy controls (HCs), participant sampling/recruiting, standardized forms, study preregistration, region of interest (ROI) analyses, validation data sets, data sharing, preprocessing documentation, and analysis software. The second iteration of the questionnaire covered scanner-related factors, sequence-related factors, physiology monitoring, and stimulation-related factors. Items showing strong consensus/consensus (≥90%/≥75% of participants indicating scores 4 or 5) were included as standard reporting items. RESULTS: All 3 rounds of the first/second iteration were completed by 29 and 26 researchers (age 46 ± 11 years; 38% female/age 46 ± 12 years; 44% female) from 23 and 21 institutions. Across both iterations, strong consensus and consensus was achieved for 34 (3 scanner-related factors, 9 sequence-related factors, 1 stimulation-related factor, 2 demographic factors, 7 migraine-specific factors, 2 medication-factors, 2 scan timing factors, 4 HC factors, 1 preregistration factor, 1 analysis software factor, and 2 ROI analyses factors) and 33 (1 scanner-related factors, 4 sequence related factors, 1 factor related to physiology monitoring, 1 stimulation-related factor, 3 demographic factors, 6 migraine-specific factors, 4 medication factors, 3 HC factors, 2 sampling factors, 1 standardized form, 1 preregistration factor, 1 data sharing factor, 2 analysis software factors, and 3 ROI analyses factors) items, respectively. From these, a checklist covering 63 items from 14 reporting domains was created. DISCUSSION: We present an expert-based framework for reporting standards in fMRI studies of migraine, which can be used for future studies to homogenize cohort characterization, fMRI acquisitions, and analysis protocols.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Schramm S, Börner-Schröder C, Reichert M, et al. Consensus Recommendations to Establish Reporting Standards in fMRI of Migraine: A Delphi Study. Neurology. 2025. PMID: 39928906. doi:10.1212/WNL.0000000000210235

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。